relys

relys is owned by Sildeha Pharma SA, headquartered in Switzerland. No. The ultimate owner of relys, Sildeha Pharma SA, is headquartered in Switzerland, not in the United States.

Sildeha Pharma is a Swiss pharmaceutical company specializing in the research, development, and marketing of innovative ophthalmic medical devices and formulations.